cualquier protocolo debe definirlo el investigador segn su diseo experimental
Back Tschp, MH, Finan, B, Clemmensen, C, et al (July 2016) 'Unimolecular polypharmacy for treatment of diabetes and obesity', Cell Metabolism , 24, 51-62
There were 15 (0.1%) of these cardiovascular events recorded with Wegovy, and 39 events (0.4%) were recorded with tirzepatide
The World Health Organization (WHO) estimates about Globally, about 589 million adults between the ages of 20 and 79 have diabetes, and 90% of diabetes cases are type 2 diabetes
Explicit marketing towards GLP-1 users may therefore be a mistake, as that risks turning off others who are also looking for products that are nutrient dense, high protein, etc, but who may think the product being marketed is not for them